Skip to content

Study on tracing of Ilioinguinal lymph nodes in penile cancer patients with carbon nanoparticle suspension injection

Study on naked eye tracing of Ilioinguinal lymph nodes in penile cancer patients with carbon nanoparticle suspension injection

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063416
Enrollment
Unknown
Registered
2022-09-06
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Penile cancer

Interventions

Carbon nanoparticles injection group:The suspension of carbon nanoparticles was injected
Control group:No drug was injected

Sponsors

Lu'an Affiliated Hospital of Anhui Medical University (Lu’an People’s Hospital)
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Patients with penile squamous cell carcinoma (>= pT1G2cN0) without surgical treatment or radiotherapy were selected 2. Consent and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1, serious organ dysfunction or disease, such as heart, brain, lung, kidney and other serious diseases and dysfunction; 2. uncorrected coagulopathy; 3, infectious disease active period, such as tuberculosis, hepatitis, etc.

Design outcomes

Primary

MeasureTime frame
Number of black-stained lymph nodes;Operation time;Positive rate of black stained lymph nodes;detection rate of lymph node;

Countries

China

Contacts

Public ContactChengyi Liu

Lu'an Affiliated Hospital of Anhui Medical University (Lu’an People’s Hospital)

liucy89@qq.com+86 13395646198

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026